A detailed history of Fred Alger Management, LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 64,576 shares of MDGL stock, worth $17.5 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
64,576
Previous 18,097 256.83%
Holding current value
$17.5 Million
Previous $4.19 Million 311.85%
% of portfolio
0.09%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$171.37 - $283.23 $7.97 Million - $13.2 Million
46,479 Added 256.83%
64,576 $17.2 Million
Q4 2023

Feb 14, 2024

SELL
$120.4 - $237.13 $212,746 - $419,008
-1,767 Reduced 8.9%
18,097 $4.19 Million
Q3 2023

Nov 14, 2023

BUY
$146.04 - $225.78 $66,594 - $102,955
456 Added 2.35%
19,864 $2.9 Million
Q2 2023

Aug 14, 2023

SELL
$203.88 - $312.0 $297,257 - $454,896
-1,458 Reduced 6.99%
19,408 $4.48 Million
Q1 2023

May 15, 2023

BUY
$231.06 - $307.08 $1.1 Million - $1.46 Million
4,746 Added 29.44%
20,866 $5.05 Million
Q4 2022

Feb 14, 2023

BUY
$58.39 - $296.54 $941,246 - $4.78 Million
16,120 New
16,120 $4.68 Million
Q3 2019

Nov 14, 2019

SELL
$84.4 - $106.53 $928,400 - $1.17 Million
-11,000 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$91.13 - $142.5 $668,256 - $1.04 Million
-7,333 Reduced 40.0%
11,000 $1.15 Million
Q1 2019

May 14, 2019

SELL
$103.48 - $143.84 $20,178 - $28,048
-195 Reduced 1.05%
18,333 $2.3 Million
Q4 2018

Feb 14, 2019

BUY
$94.77 - $215.54 $547,960 - $1.25 Million
5,782 Added 45.36%
18,528 $2.09 Million
Q3 2018

Nov 14, 2018

SELL
$207.3 - $300.31 $473,058 - $685,307
-2,282 Reduced 15.18%
12,746 $2.73 Million
Q2 2018

Jul 19, 2018

BUY
$101.55 - $313.9 $612,143 - $1.89 Million
6,028 Added 66.98%
15,028 $4.2 Million
Q1 2018

May 10, 2018

BUY
$93.35 - $149.04 $280,050 - $447,120
3,000 Added 50.0%
9,000 $1.05 Million
Q4 2017

Feb 14, 2018

BUY
$39.35 - $97.37 $236,100 - $584,220
6,000
6,000 $551,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $4.65B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.